Psoriasis is a chronic autoimmune skin disorder marked by rapid skin cell proliferation, causing red, scaly patches. Current treatments often show limited efficacy and adverse effects. The family Apiaceae is traditionally valued for its medicinal uses, particularly anti-inflammatory effects, and among its members are Deverra tortuosa (Desf.) DC. (D. tortuosa) and Deverra triradiata Hochst. ex Bioss. (D. triradiata) with recognized therapeutic value. As nanotechnology-based formulations enhance skin penetration and therapeutic efficacy, this study investigated the antipsoriatic activity of plant-based nanocreams (NCs). Phenolic content of D. tortuosa and D. triradiata aerial parts was analyzed by high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS). Nanoparticles were prepared with droplet sizes of 300–470 nm and a positive surface charge. Mice were divided into five groups: control (cream base), imiquimod (IMQU; 62.5 mg/ day for 7 days), a commonly used inducer of psoriasis-like dermatitis, standard (tacrolimus 20 mg/kg/day, 2 h after IMQU), IMQU + D. triradiata NC (2% once daily, 2 h after IMQU), and IMQU + D. tortuosa NC (2% once daily, 2 h after IMQU). D. tortuosa and D. triradiata NCs significantly alleviated IMQU-induced systemic and skin-related psoriatic changes in mice by reducing spleen index, inflammatory cytokines, including interleukin-17 (IL-17), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), as well as nuclear factor kappa-B (NF-κB), signal transducer and activator of transcription-3 (STAT3), and Ki-67 expression. Histological analysis confirmed marked restoration of normal skin architecture, with D. tortuosa showing the highest therapeutic efficacy. These findings suggest that D. tortuosa and D. triradiata NCs possess promising anti-psoriatic potential, through immunomodulatory and anti-inflammatory mechanisms, with D. tortuosa demonstrating superior efficacy. They may serve as effective natural alternatives to conventional psoriasis treatments.

Anti‑psoriatic potential of nanocarrier formulated with Deverra tortuosa DC. and Deverra triradiata hochst aerial extracts: in vivo evaluation in mice

Giovanni, Caprioli;
2026-01-01

Abstract

Psoriasis is a chronic autoimmune skin disorder marked by rapid skin cell proliferation, causing red, scaly patches. Current treatments often show limited efficacy and adverse effects. The family Apiaceae is traditionally valued for its medicinal uses, particularly anti-inflammatory effects, and among its members are Deverra tortuosa (Desf.) DC. (D. tortuosa) and Deverra triradiata Hochst. ex Bioss. (D. triradiata) with recognized therapeutic value. As nanotechnology-based formulations enhance skin penetration and therapeutic efficacy, this study investigated the antipsoriatic activity of plant-based nanocreams (NCs). Phenolic content of D. tortuosa and D. triradiata aerial parts was analyzed by high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS). Nanoparticles were prepared with droplet sizes of 300–470 nm and a positive surface charge. Mice were divided into five groups: control (cream base), imiquimod (IMQU; 62.5 mg/ day for 7 days), a commonly used inducer of psoriasis-like dermatitis, standard (tacrolimus 20 mg/kg/day, 2 h after IMQU), IMQU + D. triradiata NC (2% once daily, 2 h after IMQU), and IMQU + D. tortuosa NC (2% once daily, 2 h after IMQU). D. tortuosa and D. triradiata NCs significantly alleviated IMQU-induced systemic and skin-related psoriatic changes in mice by reducing spleen index, inflammatory cytokines, including interleukin-17 (IL-17), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), as well as nuclear factor kappa-B (NF-κB), signal transducer and activator of transcription-3 (STAT3), and Ki-67 expression. Histological analysis confirmed marked restoration of normal skin architecture, with D. tortuosa showing the highest therapeutic efficacy. These findings suggest that D. tortuosa and D. triradiata NCs possess promising anti-psoriatic potential, through immunomodulatory and anti-inflammatory mechanisms, with D. tortuosa demonstrating superior efficacy. They may serve as effective natural alternatives to conventional psoriasis treatments.
2026
Anti-inflammatory; Deverra tortuosa; Deverra triradiate; HPLC–MS/MS; Nanocream; Psoriasis
262
File in questo prodotto:
File Dimensione Formato  
Anti‑psoriatic potential.pdf

accesso aperto

Tipologia: Versione Editoriale
Licenza: Creative commons
Dimensione 8.72 MB
Formato Adobe PDF
8.72 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11581/502885
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact